Bleichroeder LP’s AbbVie ABBV Stock Holding History

Bleichroeder LP’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-515	Closed	-$93.8K	–	76
2024 Q1	$93.8K	Hold	515	–	–	0.02%	59
2023 Q4	$79.8K	Hold	515	–	–	0.02%	56
2023 Q3	$76.8K	Hold	515	–	–	0.02%	52
2023 Q2	$69.4K	Hold	515	–	–	0.01%	60
2023 Q1	$82.1K	Hold	515	–	–	0.02%	56
2022 Q4	$83.2K	Hold	515	–	–	0.02%	58
2022 Q3	$69K	Hold	515	–	–	0.01%	66
2022 Q2	$79K	Hold	515	–	–	0.02%	69
2022 Q1	$83K	Hold	515	–	–	0.01%	90
2021 Q4	$70K	Hold	515	–	–	0.01%	92
2021 Q3	$56K	Hold	515	–	–	0.01%	85
2021 Q2	$58K	Hold	515	–	–	0.01%	84
2021 Q1	$56K	Hold	515	–	–	0.01%	75
2020 Q4	$55K	Hold	515	–	–	0.01%	66
2020 Q3	$45K	Hold	515	–	–	0.01%	70
2020 Q2	$51K	Buy	+515	New	+$45.3K	0.01%	65

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bleichroeder LP's ABBV Position: Q2 2024 in Review

Bleichroeder LP sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 515 shares — an estimated $93.8K sold.

Bleichroeder LP first reported a position in ABBV in Q2 2020 and held it in 16 quarters. The position peaked at $93.8K in Q1 2024. 3,370 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Bleichroeder LP reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
Bleichroeder LP sold 515 AbbVie shares in Q2 2024, an estimated $93.8K.
Bleichroeder LP first reported a position in AbbVie in Q2 2020 and held it in 16 quarters.
Bleichroeder LP's AbbVie position peaked at $93.8K in Q1 2024.
3,370 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Bleichroeder LP's 13F filing for Q2 2024, filed 13 Aug 2024.